Orgenesis Inc.
ORGS
$2.27
-$0.0525-2.26%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -93.57% | -96.97% | -98.17% | -98.53% | -52.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -93.57% | -96.97% | -98.17% | -98.53% | -52.24% |
| Cost of Revenue | -79.01% | -85.70% | -43.64% | 21.86% | 206.74% |
| Gross Profit | -115.90% | -105.33% | -116.03% | -118.53% | -79.18% |
| SG&A Expenses | -67.54% | -72.39% | 5.31% | 125.38% | 246.05% |
| Depreciation & Amortization | -8.20% | -20.81% | -24.72% | -20.86% | -13.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -55.64% | -67.93% | -20.41% | 21.04% | 36.95% |
| Operating Income | 44.22% | 53.58% | -73.79% | -592.26% | -212.91% |
| Income Before Tax | 39.86% | 48.19% | -63.99% | -438.84% | -271.21% |
| Income Tax Expenses | -111.20% | -34.29% | 6.82% | 126.32% | 882.50% |
| Earnings from Continuing Operations | 40.81% | 48.09% | -63.38% | -433.47% | -274.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -87.40% | -89.65% | 391.24% | 451.36% | 6,191.59% |
| Net Income | 34.87% | 42.50% | -50.43% | -271.82% | -234.23% |
| EBIT | 44.22% | 53.58% | -73.79% | -592.26% | -212.91% |
| EBITDA | 45.94% | 54.68% | -84.12% | -810.35% | -240.84% |
| EPS Basic | 51.23% | 53.11% | -7.50% | -233.12% | -199.60% |
| Normalized Basic EPS | 43.80% | 46.03% | -12.08% | -120.20% | -120.35% |
| EPS Diluted | 51.29% | 53.18% | -7.29% | -231.69% | -200.00% |
| Normalized Diluted EPS | 43.80% | 46.03% | -12.08% | -120.20% | -120.35% |
| Average Basic Shares Outstanding | 34.80% | 24.52% | 19.10% | 14.67% | 11.69% |
| Average Diluted Shares Outstanding | 34.80% | 24.52% | 19.10% | 14.67% | 11.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |